Duchenne Muscular Dystrophy Calves

Duchenne, Solid and Bio

Duchenne gene therapy from Solid Biosciences produces promising results in early study

Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise

BioPharma Dive · 14h

Solid says early data suggest ‘differentiated’ Duchenne gene therapy

The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including Sarepta Therapeutics’ Elevidys.

Seeking Alpha on MSN · 17h

Solid Bio surges after trial data for lead asset in Duchenne

Solid Biosciences (SLDB) stock surges after strong Phase 1/2 data for its Duchenne therapy SGT-003. Read more here.

MarketWatch · 16h

Solid Biosciences Shares Rise After Positive Trial Data for SGT-003 in Duchenne MD

Solid Biosciences shares were up 50% to $6.06 after the company said it saw positive initial data from a Phase 1/2 trial evaluating SGT-003, a gene therapy product candidate intended for the treatment of Duchenne muscular dystrophy.

WebMD1mon

Understanding Muscular Dystrophy: Symptoms

Most children with Duchenne muscular dystrophy will need a wheelchair to ... Muscle weakness in the shoulders, upper arms, upper back, and lower legs Difficulty raising the arms or lifting ...

STAT12d

Remembering a remarkable Duchenne champion

Patient advocate Austin Leclaire, who died Feb. 1, played a pivotal role in spurring the development of the first medicines ...

Labroots19h

New Insights Into Duchenne Muscular Dystrophy Reveal Therapeutic Options

Muscular dystrophy is a disease caused by a genetic mutation. The muscles of muscular dystrophy patients weaken.. | Genetics And Genomics ...

6don MSN

Genetic mechanisms underlying Duchenne muscular dystrophy point to potential treatments

Duchenne muscular dystrophy (DMD) is a rare hereditary disease that is associated with progressive muscle wasting. The ...

MedPage Today4d

Duchenne Muscular Dystrophy

Older age, presence of scoliosis, and other factors were associated with lower predicted forced vital capacity in patients with Duchenne muscular dystrophy using non-invasive ventilation.

Managed Healthcare Executive6d

Entrada Therapeutics On Track For New DMD Study in the U.K.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Verywell Health on MSN9mon

Duchenne Muscular Dystrophy (DMD) Symptoms

Duchenne muscular dystrophy (DMD) is a genetic disorder that ... Early symptoms of muscle weakness begin in the arms ...

MedPage Today5d

Are Patients with Duchenne Muscular Dystrophy Getting Adequate Neurodevelopmental and Psychiatric Screening?

—Surveys of caregivers and health care providers reveal gaps in screening and management of neuropsychiatric and neurodevelopmental symptoms among patients with Duchenne muscular dystrophy in ...

Investor's Business Daily on MSN4mon

Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up

Muscles in the face, shoulders, arms and legs begin to waste away ... dystrophy type 1 and a subset of patients with ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results